News & Alerts
-
Nov- 2023 -29 November
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
PRISM BioLab, Co. Ltd. (“PRISM”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI)…
Read More » -
28 November
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
AUDIENCE: Patient, Health Professional, Neurology, Dermatology, Allergy and Immunology, Pharmacy ISSUE: The FDA is warning that the antiseizure medicines, Keppra,…
Read More » -
28 November
Unomedical A/S Recalls VariSoft Infusion Sets Due to Damage to the Connector Piece Causing Unexpected Disconnections
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices…
Read More » -
28 November
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require…
Read More » -
28 November
PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings
PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB:RXMD), has announced a significant expansion of its in-pharmacy offerings through…
Read More » -
28 November
Medications: The Leading Cause of Accidental Poisoning Deaths in Children
New Research Reveals Medications Are the Leading Cause of Accidental Poisoning Deaths Among Children Today “Safe Storage, Safe Dosing” Campaign…
Read More » -
28 November
Dropper Market to increase by USD 58.48 million between 2022 to 2027 – Technavio
The global dropper market is poised for substantial growth, with a projected increase of USD 58.48 million from 2022 to…
Read More » -
28 November
Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA
Daewoong Pharmaceutical Co., Ltd., headquartered in Seoul, South Korea, has achieved a significant milestone by receiving Good Manufacturing Practice (GMP)…
Read More » -
27 November
Global Artemisinin Combination Therapy Market Report 2023 – Growing R&D of New Artemisinin Combination Therapies
The Global Artemisinin Combination Therapy Market has witnessed significant growth, with a steady rise in demand, driven by escalating research…
Read More » -
27 November
Novo Rations Ozempic Starter Kits Amid Surge in Use for Weight Loss
(Reuters) – Novo Nordisk will ration starter kits of Ozempic in Europe and reduce supplies of another diabetes drug, Victoza,…
Read More »